Kilpane (28 gm) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Glaxo Smithkline Pharmaceuticals Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Menthol, Eucalyptus Oil,Methyl Salicylate. This drug comes in the form of Cream. The general packing available for this medicine consists of 28 gm and is priced at Rs 26.85 (arround $0.3759 US Dollar)
For more details on Menthol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Menthol..
Eucalyptus Oil Indication (Prescribed for or used as):
For more details on Eucalyptus Oil, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Eucalyptus Oil..
Methyl Salicylate Indication (Prescribed for or used as):
For more details on Methyl Salicylate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Methyl Salicylate..
Kilpane (28 gm) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Kilpane (28 gm), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Eucalyptus Oil-1.5% w/w Menthol-6% w/w Methyl Salicylate-15% w/w). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.
Brand
Price (Rs.)
Brand
Price (Rs.)
Kilpane (28 gm) Cream
Kilpane (28 gm) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Glaxo Smithkline Pharmaceuticals Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Eucalyptus Oil, Menthol,Methyl Salicylate. This drug comes in the form of Cream. The general packing available for this medicine consists of 28 gm and is priced at Rs 26.85 (arround $0.3759 US Dollar)
Eucalyptus Oil Indication (Prescribed for or used as):
For more details on Eucalyptus Oil, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Eucalyptus Oil..
Menthol Indication (Prescribed for or used as):
For more details on Menthol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Menthol..
Methyl Salicylate Indication (Prescribed for or used as):
For more details on Methyl Salicylate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Methyl Salicylate..
Kilpane (28 gm) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Kilpane (28 gm), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Menthol-6% w/w Methyl Salicylate-15% w/w Eucalyptus Oil-1.5% w/w). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.